Preoperative single-dose intravenous dexamethasone during ambulatory surgery: update around the benefit versus risk
- PMID: 20847689
- DOI: 10.1097/ACO.0b013e32833ff302
Preoperative single-dose intravenous dexamethasone during ambulatory surgery: update around the benefit versus risk
Abstract
Purpose of review: Pain, emesis, and fatigue are not uncommon symptoms after ambulatory surgery having impact on patients' satisfaction with quality of care. Multimodal management of postoperative pain and nausea and vomiting has become standard of care.
Recent findings: There is a growing body of evidence for the beneficial effects from preoperative single-dose intravenous (i.v.) glucocorticoids for reducing pain, emesis, and fatigue, thereby improving the recovery process and patient satisfaction. Side-effects are infrequently reported.
Summary: The benefits versus risk associated to single preoperative i.v. dose of dexamethasone seem positive based on current evidence facilitating the recovery reducing pain and postoperative nausea and vomiting.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
